STOCK TITAN

Hydrofarm (HYFM) hit with Nasdaq notice over $63.3M equity deficit

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Hydrofarm Holdings Group, Inc. received a Nasdaq notice on April 1, 2026 for failing to meet the Nasdaq Capital Market’s minimum stockholders’ equity requirement. Its Annual Report showed a stockholders’ deficit of ($63,296,000) as of December 31, 2025, below the required $2.5 million equity threshold.

The company also did not meet alternative standards tied to market value of listed securities or net income. Hydrofarm’s shares remain listed under “HYFM” while it prepares a plan by May 16, 2026 to regain compliance, with a possible extension to September 28, 2026 if Nasdaq accepts its plan.

Positive

  • None.

Negative

  • Nasdaq equity noncompliance and delisting risk: Hydrofarm reports a stockholders’ deficit of ($63,296,000), below Nasdaq’s $2.5 million minimum equity requirement, and does not meet alternative market-value or net-income standards, creating a risk of eventual suspension or delisting if compliance is not regained.

Insights

Nasdaq noncompliance highlights deep equity deficit and listing risk.

Hydrofarm reports a stockholders’ deficit of ($63,296,000), far below Nasdaq’s $2.5 million minimum equity requirement under Listing Rule 5550(b)(1). It also fails alternative tests based on market value of listed securities and net income from continuing operations.

The stock remains on the Nasdaq Capital Market while the company has until May 16, 2026 to submit a remediation plan, with potential extension to September 28, 2026. Actual outcomes will depend on Nasdaq’s acceptance of the plan and Hydrofarm’s ability to address its negative equity and liquidity and capital-access risks described in its disclosures.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Stockholders’ deficit ($63,296,000) As reported in Form 10-K for year ended December 31, 2025
Nasdaq minimum stockholders’ equity $2.5 million Listing Rule 5550(b)(1) requirement for Nasdaq Capital Market
Alternative market value standard $35 million Market value of listed securities compliance alternative
Alternative net income standard $500,000 Net income from continuing operations test for most recent year or two of last three years
Plan submission deadline May 16, 2026 45 days from April 1, 2026 to submit compliance plan
Maximum extension date September 28, 2026 Up to 180 days from April 1, 2026 to regain compliance if plan accepted
stockholders’ deficit financial
"the Company’s stockholders’ deficit of ($63,296,000) as reported in the Company’s Annual Report"
Stockholders’ deficit is the situation where a company’s total liabilities exceed its total assets, so the book value attributed to shareholders is negative. Think of it like a household with more outstanding debts than the value of its house and possessions—this can signal past losses or aggressive payouts and raises the risk that shareholders may be wiped out, diluted, or face difficulty when the company needs new financing. Investors watch it as a warning about solvency and long‑term financial health.
Nasdaq Capital Market financial
"for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1)"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Listing Rule 5550(b)(1) regulatory
"for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ deficit"
Listing Rule 5550(b)(1) is a Nasdaq listing standard that sets a minimum share price requirement companies must meet to stay listed on the exchange. It matters to investors because falling below that threshold can trigger delisting procedures, which often reduce a stock’s visibility, trading liquidity and value; think of it like a minimum score needed to remain in a sports league — miss it and you risk being dropped until you improve.
market value of listed securities financial
"did not meet the alternative compliance standards relating to the market value of listed securities of $35 million"
The market value of listed securities is the total worth of stocks, bonds and other tradable instruments quoted on an exchange, measured using the prices investors are willing to pay right now. It’s calculated by multiplying each security’s current market price by the number of units outstanding and adding those amounts together, like totaling the value of every item in a store at today’s prices. Investors watch this because it shows the size, liquidity and overall health of the market or a company’s publicly traded portion, and it influences index weights, fund allocations and perceived risk.
continued listing requirements regulatory
"the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market"
Rules a stock exchange sets that a publicly traded company must keep meeting to stay listed and tradable on that exchange, such as minimum share price, market value, timely financial reports, and basic governance practices. Like a club’s membership rules, they matter because falling short can lead to warnings, penalties or removal from the exchange, which can cut liquidity, hurt share value and increase the risk for investors.
false 0001695295 0001695295 2026-04-01 2026-04-01
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 1, 2026

Hydrofarm Holdings Group, Inc.
(Exact name of registrant as specified in its charter)

Delaware
 
001-39773
 
81-4895761
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
1510 Main Street 
ShoemakersvillePA 19555

(Address of Principal Executive
Offices) (Zip Code)
 
Registrant’s telephone number, including area code: (707765-9990

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
HYFM
Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
On April 1, 2026, Hydrofarm Holdings Group, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ deficit of ($63,296,000) as reported in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 was below the required minimum of $2.5 million, and because, as of March 31, 2026, the Company did not meet the alternative compliance standards relating to the market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.
 
The Letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on the Nasdaq Capital Market under the symbol “HYFM,” subject to the Company’s compliance with the other continued listing requirements. The Company has 45 calendar days from April 1, 2026, or until May 16, 2026, to submit to Nasdaq a plan to regain compliance with Listing Rule 5550(b)(1). If Nasdaq accepts the Company’s plan, Nasdaq may grant an extension of up to 180 calendar days from April 1, 2026, or until September 28, 2026, to regain compliance. If Nasdaq does not accept the Company’s plan, the Company will have the right to appeal such decision to a Nasdaq hearings panel. The hearing request would stay any suspension or delisting action pending the issuance of a written panel decision.
 
The Company is currently evaluating various courses of action to regain compliance and intends to submit to Nasdaq, within the requisite time period, a plan to regain compliance with Listing Rule 5550(b)(1). There can be no assurance that Nasdaq will accept the Company’s plan or that the Company will be able to regain compliance with Listing Rule 5550(b)(1) or maintain compliance with any other Nasdaq requirement in the future.
 
The Company, by filing this Current Report on Form 8-K, discloses its receipt of the notification from Nasdaq in accordance with Listing Rule 5810(b).
 
Forward Looking Statements
 
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. These statements include statements made about the Company’s intent or ability to regain compliance with the minimum stockholders’ equity requirement and other continued listing requirements. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond the Company’s control, include risks described in the section entitled “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K filing made with the SEC on March 27, 2026, and the Company’s other Exchange Act filings. In addition, these forward-looking statements may be subject to risks and uncertainties related to the Company’s ability to meet the continued listing standards of the Nasdaq Capital Market; the Company’s current level of indebtedness; the Company’s ability to maintain and preserve liquidity due to a variety of reasons, including industry conditions such as oversupply, fluctuations in the price of products and competitive industry pressures; and the Company’s ability to access additional sources of capital. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. The Company disclaims any obligation to update these forward-looking statements. All forward-looking statements in this document are qualified in their entirety by this cautionary statement.
 

 
SIGNATURES 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Hydrofarm Holdings Group, Inc.
 
 
 
 
Date: April 7, 2026
By:
/s/ William Toler
 
 
Name:
William Toler
 
 
Title:
Chief Executive Officer & Executive Chairman of the Board of Directors
 
 
 
(Principal Executive Officer)
 

FAQ

What Nasdaq notice did Hydrofarm (HYFM) receive on April 1, 2026?

Hydrofarm received a Nasdaq Listing Qualifications notice stating it no longer meets the Nasdaq Capital Market’s minimum stockholders’ equity requirement. The company reported a stockholders’ deficit of ($63,296,000), which is below the required $2.5 million stockholders’ equity threshold under Listing Rule 5550(b)(1).

Is Hydrofarm’s HYFM stock being delisted from Nasdaq now?

No, Hydrofarm’s common stock continues to trade on the Nasdaq Capital Market under the symbol HYFM. The notice has no immediate impact on listing status while the company prepares and submits a plan to regain compliance within the Nasdaq-prescribed timeframes.

How large is Hydrofarm’s stockholders’ deficit compared with Nasdaq’s requirement?

Hydrofarm reported a stockholders’ deficit of ($63,296,000) in its Form 10-K for the year ended December 31, 2025. Nasdaq’s Listing Rule 5550(b)(1) requires minimum stockholders’ equity of $2.5 million for continued listing on the Nasdaq Capital Market.

What deadlines does Hydrofarm face to regain Nasdaq listing compliance?

Hydrofarm has 45 calendar days from April 1, 2026, until May 16, 2026, to submit a plan to regain compliance. If Nasdaq accepts the plan, it may grant up to 180 calendar days, through September 28, 2026, to restore compliance.

Which alternative Nasdaq standards did Hydrofarm (HYFM) fail to meet?

As of March 31, 2026, Hydrofarm did not satisfy alternative requirements based on a $35 million market value of listed securities or net income from continuing operations of $500,000 in the most recent fiscal year or two of the last three fiscal years.

What actions does Hydrofarm plan after the Nasdaq noncompliance notice?

Hydrofarm is evaluating various courses of action to regain compliance and intends to submit a plan to Nasdaq within the required 45-day period. The company notes there is no assurance Nasdaq will accept its plan or that compliance will be regained.

Filing Exhibits & Attachments

4 documents